Skip to content
Home/Companies/Healthcare/Ipsophene

Ipsophene

Healthcare·France·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Ipsophene?

Ipsophene is a French Healthcare company, currently owned by Grand Sud-Ouest Capital since 2018.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Grand Sud-Ouest Capital
Investor
Grand Sud-Ouest Capital
Grand Sud Ouest Capital · 1991 · Buyout

Key facts

HQFrance
SectorHealthcare

More from Grand Sud Ouest Capital

Other portfolio companies in the same fund.

Ethiquable
Ethiquable
Active
ConsumerFrance
Hyd&au
Active
IndustrialsFrance
Maison Bertrand Ravache
Active
France
Groupe SYNELIS
Active
France· 2026
i-Run
i-Run
Active
ConsumerFrance· 2026
Nexteam Group
Active
Aerospace & DefenceFrance· 2026

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Ipsophene?

Ipsophene is currently owned by Grand Sud-Ouest Capital, through Grand Sud Ouest Capital, since 2018.

When did Grand Sud-Ouest Capital acquire Ipsophene?

Grand Sud-Ouest Capital acquired Ipsophene in 2018.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue